JUser: :_load: Unable to load user with ID: 474

Denbury Resources Inc. (DNR) Pops 3.92% for November 21

Equities Staff |

One of the S&P 500’s big winners for Friday November 21 was Denbury Resources Inc. (DNR) as the company’s stock climbed 3.92% to $10.15 on volume of 11.8 million shares.

The stock opened at $9.949 and saw an intraday low of $9.94 and an intraday high of $10.19. All told, the day saw a per-share gain of $0.3825. The stock’s average daily volume of 6.24 million and 352.56 million shares outstanding. Denbury Resources Inc. now has a 50-day SMA is $12.83 and 200-day SMA is $15.75, and it has a 52-week high of $18.59 and a 52-week low of $9.59.

Denbury Resources Inc is a domestic oil and natural gas producer in Mississippi and Montana.

Based out of Plano, TX, Denbury Resources Inc. has 1502 employees and, after today’s trading, reached a market cap of $3.58 billion. The stock’s P/E Ratio is 9.5. Its P/S ratio is 1.36, P/B ratio is 0.67, and P/FCF ratio is 2.9.

For a full analysis of Denbury Resources Inc., check out Equities.com’s E.V.A. report for Denbury Resources Inc..

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
DNR Denbury Resources Inc. 2.62 0.20 8.26 12,063,549 Trade


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.